{name}
{subtitle}
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
city
~4 mi. (Southport, Australia, +122 more cities)
facility
Tasman Health Care
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~4 mi. (Southport, Australia, +122 more cities)
facility
Gold Coast University Hospital ( Site 3003)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~4 mi. (Southport, Australia, +137 more cities)
facility
Gold Coast University Hospital ( Site 0054)
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~4 mi. (Southport, Australia, +201 more cities)
facility
Gold coast University Hospital /ID# 222606
drug
azacitidine, +1 more drug
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~4 mi. (Southport, Australia, +197 more cities)
facility
Gold coast University Hospital /ID# 214650
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
drug
azacitidine, +1 more drug
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)
city
~4 mi. (Southport, Australia, +115 more cities)
facility
Tasman Oncology Research Pty Ltd ( Site 2203)
biomarker
ATM Loss, +27 more biomarkers
condition
Breast Carcinoma, +2 more conditions
drug
olaparib, +1 more drug
drug type
immunotherapy, +1 more type
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002)
city
~4 mi. (Southport, Australia, +76 more cities)
facility
Gold Coast University Hospital-Clinical Trials Service ( Site 0106)
drug
docetaxel, +1 more drug
drug type
chemotherapy, +1 more type
A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
city
~4 mi. (Southport, Australia, +30 more cities)
facility
Gold Coast University Hospital ( Site 0103)
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
city
~4 mi. (Southport, Australia, +78 more cities)
facility
Local Institution
drug
ipilimumab, +3 more drugs
drug type
immunotherapy, +1 more type